Follow The Filings

CRNXCrinetics Pharmaceuticals In

Q4 2022 13F holders among managers we track Latest ownership dossier

Ticker
CRNX
Type
Equity
Class
COM
Total reported value (long equity)
Manager Report date Value Shares